Literature DB >> 25708663

Intravitreal triamcinolone acetonide, retinal microglia and retinal ganglion cell apoptosis in the optic nerve crush model.

Jiawei Wang1, Shida Chen1, Xiulan Zhang1, Wenbin Huang1, Jost B Jonas2.   

Abstract

PURPOSE: To evaluate the effect of intravitreal triamcinolone acetonide (TA) on the activation of retinal microglia cells (RMGCs) and survival of retinal ganglion cells (RGCs) in an optic nerve crush (ONC) model.
METHODS: Adult female Sprague-Dawley rats underwent a standardized ONC and either received an intravitreal injection of TA (TA group) or of phosphate-buffered saline (PBS, PBS group) in the right eyes. At 1, 3, 7, 14 and 28 days after the ONC, the animals were killed. The retinas were examined by immunohistochemistry, light microscopy, Western blot or retrograde labelling of RGCs by fluorogold injected into the superior colliculi.
RESULTS: The TA group as compared to the PBS control group showed a significantly (p < 0.0001) lower density of activated RMGCs, at 14 days [4.2 ± 1.6 versus 9.3 ± 2.2 cells/high-power microscopic field (HPF)] and at 28 days (2.3 ± 1.1 versus 4.4 ± 1.5 cells/HPF), and with a significantly lower expression of inflammatory factors. Central density of RGCs as stained by haematoxylin-eosin or by fluorogold was significantly (all p < 0.05) more reduced in the PBS group than in the TA group at days 14 and 28 after baseline. The survival rate (cell density in the study eye as compared to cell density in the contralateral unaffected eye) was significantly higher in the TA group than in the PBS group on days 14 (58% versus 45%; p = 0.003) and 28 (52% versus 41%; p = 0.022).
CONCLUSIONS: Intravitreal TA as compared to intravitreal PBS was associated with a lower density of activated RMGCs and a higher density of surviving RGCs in an ONC model.
© 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  intravitreal triamcinolone; optic nerve; optic nerve crush; retinal ganglion cells; retinal microglial cells

Mesh:

Substances:

Year:  2015        PMID: 25708663     DOI: 10.1111/aos.12698

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Internal limiting membrane peeling with different dyes in the surgery of idiopathic macular hole: a systematic review of literature and network Meta-analysis.

Authors:  Shan-Shan Li; Ran You; Min Li; Xiao-Xiao Guo; Lu Zhao; Yan-Ling Wang; Xi Chen
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

2.  Gastrodin protects retinal ganglion cells through inhibiting microglial-mediated neuroinflammation in an acute ocular hypertension model.

Authors:  Jia-Wei Wang; Yao-Ming Liu; Xiao-Fei Zhao; Han Zhang
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

3.  Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study.

Authors:  David J Valent; Wai T Wong; Emily Y Chew; Catherine A Cukras
Journal:  Transl Vis Sci Technol       Date:  2018-12-17       Impact factor: 3.283

4.  MicroRNA-93/STAT3 signalling pathway mediates retinal microglial activation and protects retinal ganglion cells in an acute ocular hypertension model.

Authors:  Yayi Wang; Shida Chen; Jiawei Wang; Yaoming Liu; Yang Chen; Tao Wen; Xiuli Fang; Manuel Vidal-Sanz; Jost B Jonas; Xiulan Zhang
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

Review 5.  Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.

Authors:  Raquel Boia; Noelia Ruzafa; Inês Dinis Aires; Xandra Pereiro; António Francisco Ambrósio; Elena Vecino; Ana Raquel Santiago
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.